Search

Thea D' Ambrosio

Examiner (ID: 2073, Phone: (571)270-1216 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1675, 1654
Total Applications
599
Issued Applications
266
Pending Applications
113
Abandoned Applications
241

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10968128 [patent_doc_number] => 20140371160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'NOVEL ALPHA-1 ANTITRYPSIN VARIANT, PREPARATION METHOD THEREOF AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/344468 [patent_app_country] => US [patent_app_date] => 2012-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10999 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344468 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344468
Alpha-1 antitrypsin variant, preparation method thereof and use thereof Aug 12, 2012 Issued
Array ( [id] => 8659126 [patent_doc_number] => 20130039954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'CONTROL OF ANTIBODY RESPONSES TO SYNTHETIC NANOCARRIERS' [patent_app_type] => utility [patent_app_number] => 13/560925 [patent_app_country] => US [patent_app_date] => 2012-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23367 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560925 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/560925
CONTROL OF ANTIBODY RESPONSES TO SYNTHETIC NANOCARRIERS Jul 26, 2012 Abandoned
Array ( [id] => 10906157 [patent_doc_number] => 20140309170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/235563 [patent_app_country] => US [patent_app_date] => 2012-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9335 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235563 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/235563
ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF Jul 22, 2012 Abandoned
Array ( [id] => 10025004 [patent_doc_number] => 09066882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-30 [patent_title] => 'Method and a system for producing thermolabile nanoparticles with controlled properties and nanoparticles matrices made thereby' [patent_app_type] => utility [patent_app_number] => 13/554798 [patent_app_country] => US [patent_app_date] => 2012-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2947 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 269 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13554798 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/554798
Method and a system for producing thermolabile nanoparticles with controlled properties and nanoparticles matrices made thereby Jul 19, 2012 Issued
Array ( [id] => 10912768 [patent_doc_number] => 20140315784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein' [patent_app_type] => utility [patent_app_number] => 14/127430 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 48144 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127430 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/127430
Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein Jun 26, 2012 Abandoned
Array ( [id] => 13196149 [patent_doc_number] => 10112984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-30 [patent_title] => Light-sensitive chimeric GPCR protein [patent_app_type] => utility [patent_app_number] => 14/128155 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7054 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128155 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/128155
Light-sensitive chimeric GPCR protein Jun 21, 2012 Issued
Array ( [id] => 9046825 [patent_doc_number] => 08541379 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Kokumi-imparting agent' [patent_app_type] => utility [patent_app_number] => 13/529482 [patent_app_country] => US [patent_app_date] => 2012-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12960 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13529482 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/529482
Kokumi-imparting agent Jun 20, 2012 Issued
Array ( [id] => 11225347 [patent_doc_number] => 09453062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof' [patent_app_type] => utility [patent_app_number] => 14/125061 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 27365 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 410 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125061 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/125061
Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof Jun 7, 2012 Issued
Array ( [id] => 9643158 [patent_doc_number] => 20140221271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'SHK-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 14/124669 [patent_app_country] => US [patent_app_date] => 2012-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12374 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124669 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/124669
SHK-based pharmaceutical compositions and methods of manufacturing and using the same Jun 4, 2012 Issued
Array ( [id] => 17843778 [patent_doc_number] => 11433120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Controlled release peptide formulations [patent_app_type] => utility [patent_app_number] => 14/117994 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16885 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117994 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117994
Controlled release peptide formulations May 24, 2012 Issued
13/474411 COMPOSITIONS AND METHODS FOR TREATING HCV May 16, 2012 Abandoned
Array ( [id] => 9561880 [patent_doc_number] => 20140179594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK' [patent_app_type] => utility [patent_app_number] => 14/112975 [patent_app_country] => US [patent_app_date] => 2012-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 32006 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112975 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/112975
STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK Apr 19, 2012 Abandoned
Array ( [id] => 9294114 [patent_doc_number] => 20140037748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'REDOX RESPONSIVE POLYMERIC NANOCAPSULES FOR PROTEIN DELIVERY' [patent_app_type] => utility [patent_app_number] => 14/110058 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16418 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110058 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110058
REDOX RESPONSIVE POLYMERIC NANOCAPSULES FOR PROTEIN DELIVERY Apr 12, 2012 Abandoned
Array ( [id] => 8482848 [patent_doc_number] => 20120282255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE' [patent_app_type] => utility [patent_app_number] => 13/441337 [patent_app_country] => US [patent_app_date] => 2012-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29470 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441337 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/441337
METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE Apr 5, 2012 Abandoned
Array ( [id] => 9293980 [patent_doc_number] => 20140037614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5' [patent_app_type] => utility [patent_app_number] => 14/110176 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7408 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110176 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/110176
THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5 Apr 4, 2012 Abandoned
Array ( [id] => 8406397 [patent_doc_number] => 20120238465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'DRUG SCREENING TARGET FOR ALZHEIMER\'S DISEASE AND METHOD OF SCREENING POTENTIAL DRUGS' [patent_app_type] => utility [patent_app_number] => 13/423239 [patent_app_country] => US [patent_app_date] => 2012-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18497 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423239 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/423239
DRUG SCREENING TARGET FOR ALZHEIMER'S DISEASE AND METHOD OF SCREENING POTENTIAL DRUGS Mar 17, 2012 Abandoned
Array ( [id] => 10038233 [patent_doc_number] => 09078928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS' [patent_app_type] => utility [patent_app_number] => 14/005688 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 11508 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005688 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/005688
Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS Mar 15, 2012 Issued
Array ( [id] => 10038233 [patent_doc_number] => 09078928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS' [patent_app_type] => utility [patent_app_number] => 14/005688 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 11508 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005688 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/005688
Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS Mar 15, 2012 Issued
Array ( [id] => 9041594 [patent_doc_number] => 20130244232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/421340 [patent_app_country] => US [patent_app_date] => 2012-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13653 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421340 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/421340
HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF Mar 14, 2012 Abandoned
Array ( [id] => 10600255 [patent_doc_number] => 09320803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Bisphosphonate-prodrugs' [patent_app_type] => utility [patent_app_number] => 14/001387 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 8221 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001387 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/001387
Bisphosphonate-prodrugs Feb 23, 2012 Issued
Menu